肝癌术后复发风险预测及干预策略

被引:7
作者
陆伟东
李风伟
张小峰
李俊
王葵
沈锋
机构
[1] 海军军医大学东方肝胆外科医院
关键词
肝细胞癌; 术后复发; 预测; 干预;
D O I
10.19538/j.cjps.issn1005-2208.2019.10.04
中图分类号
R735.7 [肝肿瘤];
学科分类号
100112 [医学生物化学与分子生物学];
摘要
肝细胞癌是世界上最常见的恶性肿瘤之一,肝切除术和肝移植是其最重要的治疗方法,但术后肿瘤的高复发率显著降低了长期存活率。微血管侵犯(MVI)可预测术后肿瘤复发的风险,是肝切除术后复发的独立危险因素。临床应重点关注如何制定经组织病理学检查证实MVI的肝细胞癌病人的术后抗复发措施,以及应用预测模型指导外科治疗方法的个体化选择,明确复发预防重点对象,提高抗复发的效率。
引用
收藏
页码:1021 / 1024
页数:4
相关论文
共 24 条
[1]
Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection [J].
He, Chao ;
Peng, Wei ;
Li, Chuan ;
Wen, Tian-Fu .
MEDICINE, 2017, 96 (16)
[2]
Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[3]
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial [J].
Bruix, Jordi ;
Takayama, Tadatoshi ;
Mazzaferro, Vincenzo ;
Chau, Gar-Yang ;
Yang, Jiamei ;
Kudo, Masatoshi ;
Cai, Jianqiang ;
Poon, Ronnie T. ;
Han, Kwang-Hyub ;
Tak, Won Young ;
Lee, Han Chu ;
Song, Tianqiang ;
Roayaie, Sasan ;
Bolondi, Luigi ;
Lee, Kwan Sik ;
Makuuchi, Masatoshi ;
Souza, Fabricio ;
Le Berre, Marie-Aude ;
Meinhardt, Gerold ;
Llovet, Josep M. .
LANCET ONCOLOGY, 2015, 16 (13) :1344-1354
[4]
A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma [J].
Banerjee, Sudeep ;
Wang, David S. ;
Kim, Hyun J. ;
Sirlin, Claude B. ;
Chan, Michael G. ;
Korn, Ronald L. ;
Rutman, Aaron M. ;
Siripongsakun, Surachate ;
Lu, David ;
Imanbayev, Galym ;
Kuo, Michael D. .
HEPATOLOGY, 2015, 62 (03) :792-800
[5]
Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection [J].
Cheng, Zhangjun ;
Yang, Pinghua ;
Qu, Shuping ;
Zhou, Jiahua ;
Yang, Jue ;
Yang, Xinwei ;
Xia, Yong ;
Li, Jun ;
Wang, Kui ;
Yan, Zhenlin ;
Wu, Dong ;
Zhang, Baohua ;
Hueser, Norbert ;
Shen, Feng .
HPB, 2015, 17 (05) :422-427
[6]
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion [J].
Pote, Nicolas ;
Cauchy, Franois ;
Albuquerque, Miguel ;
Voitot, Helene ;
Belghiti, Jacques ;
Castera, Laurent ;
Puy, Herve ;
Bedossa, Pierre ;
Paradis, Valerie .
JOURNAL OF HEPATOLOGY, 2015, 62 (04) :848-854
[7]
Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit [J].
Vitale, A. ;
Cucchetti, A. ;
Qiao, G. L. ;
Cescon, M. ;
Li, J. ;
Morales, R. Ramirez ;
Frigo, A. C. ;
Xia, Y. ;
Tuci, F. ;
Shen, F. ;
Cillo, U. ;
Pinna, A. D. .
JOURNAL OF HEPATOLOGY, 2014, 60 (06) :1165-1171
[8]
Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma [J].
Cucchetti, Alessandro ;
Qiao, Guo-Liang ;
Cescon, Matteo ;
Li, Jun ;
Xia, Yong ;
Ercolani, Giorgio ;
Shen, Feng ;
Pinna, Antonio Daniele .
SURGERY, 2014, 155 (03) :512-521
[9]
Microvascular invasion in small hepatocellular carcinoma: Is it predictable with preoperative diffusion-weighted imaging? [J].
Xu, Pengju ;
Zeng, Mengsu ;
Liu, Kai ;
Shan, Yan ;
Xu, Chen ;
Lin, Jiang .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (02) :330-336
[10]
Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma [J].
Zhao, W. -C. ;
Fan, L. -F. ;
Yang, N. ;
Zhang, H. -B. ;
Chen, B. -D. ;
Yang, G. -S. .
EJSO, 2013, 39 (08) :858-864